Evidence map›Paper›PMID 29914064›Full record

ReviewViruses2018

The Diversity of Bacterial Lifestyles Hampers Bacteriophage Tenacity.

Marta Lourenço, Luisa De Sordi, Laurent Debarbieux

Abstract readReview
In one paragraph

Review in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Harnessing phages to tackle antimicrobial resistance: a Saudi Arabian perspective.Frontiers in cellular and infection microbiology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. New insights into intestinal phages.Mucosal immunology · 2020
    Review
  12. Shining Light on Human Gut Bacteriophages.Frontiers in cellular and infection microbiology · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marta LourençoDepartment of Microbiology, Institut Pasteur, F-75015 Paris, France. marta.mansos-lourenco@pasteur.fr.
Luisa De SordiDepartment of Microbiology, Institut Pasteur, F-75015 Paris, France. luisa.de-sordi@pasteur.fr.
Laurent DebarbieuxDepartment of Microbiology, Institut Pasteur, F-75015 Paris, France. laurent.debarbieux@pasteur.fr.ORCID 0000-0001-6875-5758

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phage therapy is based on a simple concept: the use of a virus (bacteriophage) that is capable of killing specific pathogenic bacteria to treat bacterial infections. Since the pioneering work of Félix d’Herelle, bacteriophages (phages) isolated in vitro have been shown to be of therapeutic value. Over decades of study, a large number of rather complex mechanisms that are used by phages to hijack bacterial resources and to produce their progeny have been deciphered. While these mechanisms have been identified and have been studied under optimal conditions in vitro, much less is known about the requirements for successful viral infections in relevant natural conditions. This is particularly true in the context of phage therapy. Here, we highlight the parameters affecting phage replication in both in vitro and in vivo environments, focusing, in particular, on the mammalian digestive tract. We propose avenues for increasing the knowledge-guided implementation of phages as therapeutic tools.

Indexed as

Host-Parasite InteractionsAnimalsBacteriaBacteriophagesGastrointestinal TractHumansMammalsbacteriophage efficacygastrointestinal tractphage therapyvirus–host interactions

Identifiers

PMID29914064
PMCPMC6024678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.